U.S. markets closed

Sanara MedTech Inc. (SMTI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
23.01+0.86 (+3.88%)
At close: 04:00PM EDT

Sanara MedTech Inc.

1200 Summit Avenue
Suite 414
Fort Worth, TX 76102
United States
817 529 2300

IndustryMedical Instruments & Supplies
Full Time Employees63

Key Executives

NameTitlePayExercisedYear Born
Mr. Ronald T. NixonExec. ChairmanN/AN/A1956
Mr. Zachary B. FlemingChief Exec. Officer365.8kN/A1975
Mr. Michael D. McNeilCFO & Corp. Sec.286.76kN/A1965
Mr. Shawn M. BowmanPres of Strategic Partnerships286.52kN/A1976
Mr. Callon NicholsDirector of Investor RelationsN/AN/AN/A
Mr. Bill FitzgeraldCompliance OfficerN/AN/AN/A
Dr. Jane A. ForeChief Medical OfficerN/AN/AN/A
Ms. Tricia MattesonSr. Director of MarketingN/AN/AN/A
Ms. Carla DayDirector of Customer & Sales ServicesN/AN/AN/A
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D.Pres of Telehealth ServicesN/AN/A1970
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Corporate Governance

Sanara MedTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.